Literature DB >> 25355446

Concurrence of multiple human papillomavirus infections in a large US population-based cohort.

Zihua Yang, Jack Cuzick, William C Hunt, Cosette M Wheeler.   

Abstract

We examined the concurrence of multiple human papillomavirus (HPV) infections in 47,617 women who underwent cervical screening in New Mexico between December 2007 and April 2009 using the LINEAR ARRAY HPV Genotyping Test (Roche Diagnostics, Indianapolis, Indiana), which detects 37 different types of HPV. Our primary goal was to examine the distributions of multiple HPV types with a special interest in negative interactions, which could signal the possibility of type replacement associated with a common niche if some HPV types were prevented by vaccination. Multiple infections were found to be more common than expected under independence, but this could largely be accounted for by a woman-specific latent heterogeneity parameter which was found to be dependent on age and cytological grade. While multiple infections were more common in young women and in those with abnormal cytology, greater heterogeneity was seen in older women and in those with normal cytology, possibly reflecting greater variability in exposure due to current or past HPV exposure or due to heterogeneity in related HPV reactivation or in immune responses to HPV infection or persistence. A negative interaction was found between HPV 16 and several other HPV types for women with abnormal cytology but not for those with normal cytology, suggesting that type replacement in women vaccinated against HPV 16 is unlikely to be an issue for the general population.
© The Author 2014. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  cervical screening; human papillomavirus; multiple infections; population heterogeneity

Mesh:

Year:  2014        PMID: 25355446      PMCID: PMC4239798          DOI: 10.1093/aje/kwu267

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  19 in total

Review 1.  Clinical utility of HPV genotyping.

Authors:  Chris J Meijer; Peter J Snijders; Philip E Castle
Journal:  Gynecol Oncol       Date:  2006-08-24       Impact factor: 5.482

2.  One virus, one lesion--individual components of CIN lesions contain a specific HPV type.

Authors:  Wim Quint; David Jenkins; Anco Molijn; Linda Struijk; Miekel van de Sandt; John Doorbar; Johann Mols; Christine Van Hoof; Karin Hardt; Frank Struyf; Brigitte Colau
Journal:  J Pathol       Date:  2012-02-17       Impact factor: 7.996

3.  A modeling framework for the analysis of HPV incidence and persistence: a semi-parametric approach for clustered binary longitudinal data analysis.

Authors:  Xiangrong Kong; Ronald H Gray; Lawrence H Moulton; Maria Wawer; Mei-Cheng Wang
Journal:  Stat Med       Date:  2010-12-10       Impact factor: 2.373

4.  Contributions of recent and past sexual partnerships on incident human papillomavirus detection: acquisition and reactivation in older women.

Authors:  Anne F Rositch; Anne E Burke; Raphael P Viscidi; Michelle I Silver; Kathryn Chang; Patti E Gravitt
Journal:  Cancer Res       Date:  2012-09-27       Impact factor: 12.701

5.  Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease.

Authors:  Anil K Chaturvedi; Hormuzd A Katki; Allan Hildesheim; Ana Cecilia Rodríguez; Wim Quint; Mark Schiffman; Leen-Jan Van Doorn; Carolina Porras; Sholom Wacholder; Paula Gonzalez; Mark E Sherman; Rolando Herrero
Journal:  J Infect Dis       Date:  2011-04-01       Impact factor: 5.226

6.  A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica.

Authors:  Philip E Castle; Mark Schiffman; Rolando Herrero; Allan Hildesheim; Ana Cecilia Rodriguez; M Concepcion Bratti; Mark E Sherman; Sholom Wacholder; Robert Tarone; Robert D Burk
Journal:  J Infect Dis       Date:  2005-05-02       Impact factor: 5.226

7.  A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion.

Authors:  Martyn Plummer; Mark Schiffman; Philip E Castle; Delphine Maucort-Boulch; Cosette M Wheeler
Journal:  J Infect Dis       Date:  2007-04-16       Impact factor: 5.226

8.  Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination.

Authors:  Helen Trottier; Salaheddin Mahmud; José Carlos M Prado; Joao S Sobrinho; Maria C Costa; Thomas E Rohan; Luisa L Villa; Eduardo L Franco
Journal:  J Infect Dis       Date:  2008-05-15       Impact factor: 5.226

9.  Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants.

Authors:  Nicolas Wentzensen; Mark Schiffman; Terence Dunn; Rosemary E Zuna; Michael A Gold; Richard A Allen; Roy Zhang; Mark E Sherman; Sholom Wacholder; Joan Walker; Sophia S Wang
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

10.  A population-based evaluation of cervical screening in the United States: 2008-2011.

Authors:  Jack Cuzick; Orrin Myers; William C Hunt; Michael Robertson; Nancy E Joste; Philip E Castle; Vicki B Benard; Cosette M Wheeler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-03       Impact factor: 4.254

View more
  10 in total

1.  Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction.

Authors:  Courtney Covert; Lili Ding; Darron Brown; Eduardo L Franco; David I Bernstein; Jessica A Kahn
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

2.  Invited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination.

Authors:  Mahboobeh Safaeian; Ana Cecilia Rodriguez
Journal:  Am J Epidemiol       Date:  2014-10-29       Impact factor: 4.897

3.  Shift in prevalence of HPV types in cervical cytology specimens in the era of HPV vaccination.

Authors:  Sonja Fischer; Marcus Bettstetter; Andrea Becher; Marlene Lessel; Cyril Bank; Matthias Krams; Ingrid Becker; Arndt Hartmann; Wolfgang Jagla; Andreas Gaumann
Journal:  Oncol Lett       Date:  2016-06-01       Impact factor: 2.967

4.  National- and state-level impact and cost-effectiveness of nonavalent HPV vaccination in the United States.

Authors:  David P Durham; Martial L Ndeffo-Mbah; Laura A Skrip; Forrest K Jones; Chris T Bauch; Alison P Galvani
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-18       Impact factor: 11.205

5.  Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction.

Authors:  Lea E Widdice; David I Bernstein; Eduardo L Franco; Lili Ding; Darron R Brown; Aaron C Ermel; Lisa Higgins; Jessica A Kahn
Journal:  Vaccine       Date:  2019-09-30       Impact factor: 3.641

6.  Epidemiologic Evaluation of Human Papillomavirus Type Competition and the Potential for Type Replacement Post-Vaccination.

Authors:  Joseph E Tota; Mengzhu Jiang; Agnihotram V Ramanakumar; Stephen D Walter; Jay S Kaufman; François Coutlée; Harriet Richardson; Ann N Burchell; Anita Koushik; Marie Hélène Mayrand; Luisa L Villa; Eduardo L Franco
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

7.  Concurrent Infection With Multiple Human Papillomavirus Types Among Unvaccinated and Vaccinated 17-Year-Old Norwegian Girls.

Authors:  Ida Laake; Berit Feiring; Christine Monceyron Jonassen; John H O Pettersson; Torstein Gjølgali Frengen; Ingerid Ørjansen Kirkeleite; Lill Trogstad
Journal:  J Infect Dis       Date:  2022-09-04       Impact factor: 7.759

8.  Human papillomavirus genotypes among women with or without HIV infection: an epidemiological study of Moroccan women from the Souss area.

Authors:  Essaada Belglaiaa; Hicham Elannaz; Bouchra Mouaouya; Mohamed Aksim; Mariette Mercier; Jean-Luc Prétet; Said Chouham; Christiane Mougin
Journal:  Infect Agent Cancer       Date:  2015-12-08       Impact factor: 2.965

9.  HPV Population Profiling in Healthy Men by Next-Generation Deep Sequencing Coupled with HPV-QUEST.

Authors:  Li Yin; Jin Yao; Kaifen Chang; Brent P Gardner; Fahong Yu; Anna R Giuliano; Maureen M Goodenow
Journal:  Viruses       Date:  2016-01-25       Impact factor: 5.048

10.  Clinical Significance of the Interaction between Human Papillomavirus (HPV) Type 16 and Other High-Risk Human Papillomaviruses in Women with Cervical Intraepithelial Neoplasia (CIN) and Invasive Cervical Cancer.

Authors:  Arsenio Spinillo; Mattia Dominoni; Anna C Boschi; Cecilia Sosso; Giacomo Fiandrino; Stefania Cesari; Barbara Gardella
Journal:  J Oncol       Date:  2020-10-26       Impact factor: 4.375

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.